The 2020 Biopharmaceutical Manufacturing Conference will focus on innovation in facilities, production methods and technologies that enable a competitive and sustainable biopharmaceutical product supply for the future. This conference will bring together experts that are developing, implementing, and operating advanced supply chains providing high quality medicines to global markets.
Program presentations will address challenges of new modalities, process, operational and facility innovations, and supply chain strategies bringing reliability, efficiency, and modernization for today's manufacturing and tomorrow's new therapies. The conference will feature views and case studies by biopharmaceutical industry professionals, in additional to perspectives from regulatory officials. Regulators will provide insights on CMC approaches, and CGMP developments for emerging technologies and individualized treatments.
Whether you are producing biologic drug substance, conducting sterile fill-finish operations, or entering into cell and gene therapy, this conference will provide the latest information to help your organization have the knowledge and agility needed to meet the needs of the patients we serve.
Cell and Gene Therapies from Research to Clinical to Production
Emerging Technologies to Deliver Cell and Gene Therapies
Supply Chain Challenges and How the Industry is Meeting Them (including facility design & operations)
Monoclonal Antibodies (including ADCs) and Oligonucleotides
Harmonization: Regulatory, CMC, GMP
Join the conversation! This Women in Pharma® panel of biopharmaceutical leaders will share their insights on achieving and the value of gender balance in biopharmaceutical manufacturing. In addition, the event will include audience participation in breakout group discussions.
Note: This session is included with full conference registration.